releases: http://morgangriffith.house.gov/news/documentsingle.aspx?DocumentID=402391
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://morgangriffith.house.gov/news/documentsingle.aspx?DocumentID=402391 | Griffith Bill to Prevent Opioid Abuse Passes House | 2020-11-17 | 2020 | 2020-11 | Republican | Senate | VA | Morgan Griffith | G000568 | morgangriffith.house.gov | legacy | The U.S. House of Representatives today passed H.R. 4812, the Ensuring Compliance Against Drug Diversion Act, introduced by Congressman Morgan Griffith (R-VA). Griffith issued the following statement: The opioid crisis grew in part due to the abuse of opioids legally manufactured and sold. My bill, the Ensuring Compliance Against Drug Diversion Act, would reform Drug Enforcement Agency regulations to close legal loopholes that could enable opioid abuse. I am proud to sponsor this small but important fix that will assist in fighting the opioid epidemic that has hurt too many. Further Information The Ensuring Compliance Against Drug Diversion Act amends the Controlled Substances Act to prohibit the transfer of any Drug Enforcement Agency registration to manufacture, distribute, or dispense controlled substances without written consent from the agency. ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |